Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
about
Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.Estimation of cancer incidence and mortality attributable to alcohol drinking in China.Counseling the patient with potentially HPV-related newly diagnosed head and neck cancerAssociation between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck.Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000Periodontal disease and risk of head and neck cancer: a meta-analysis of observational studies.Tooth loss and head and neck cancer: a meta-analysis of observational studies.Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells.Oral cavity anaerobic pathogens in biofilm formation on voice prostheses.Association between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck.A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes.Voice and Functional Outcomes of Transoral Laser Microsurgery for Early Glottic Cancer: Ventricular Fold Resection as a Surrogate.Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers.Timing of neck dissection in association with transoral surgery: A systematic review.Tooth loss is associated with increased risk of esophageal cancer: evidence from a meta-analysis with dose-response analysis.Reconstruction in oral malignancy: Factors affecting morbidity of various procedures.Epidemiology and Trend of Head and Neck Cancers in Iran.Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.Head and Neck Cancers, Version 1.2015.Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients.Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas.Current status of experimental therapeutics for head and neck cancer.The psychological experience of living with head and neck cancer: a systematic review and meta-synthesis.Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma.Metformin and the risk of head and neck cancer: a case-control analysis.Roles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancer.Conceiving a national head and neck cancer screening programme.Carfilzomib and oprozomib synergize with histone deacetylase inhibitors in head and neck squamous cell carcinoma models of acquired resistance to proteasome inhibitors.Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?SET overexpression decreases cell detoxification efficiency: ALDH2 and GSTP1 are downregulated, DDR is impaired and DNA damage accumulates.Tensile Bond Strengths of Two Adhesives on Irradiated and Nonirradiated Human Dentin.Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog.Psychological support needs of patients with head and neck cancer and their caregivers: A qualitative study.
P2860
Q33712114-A474D420-8446-496F-B2C0-4F5C8EB0701BQ33756060-41A2FB89-0D82-46BD-B9E2-3CC045495D27Q33908473-098C7766-0337-46F8-9376-05E64F17D655Q33937401-EFFE6788-C95C-4AE9-9941-1B9F44519522Q34345398-F3081103-70D1-4861-8C33-ABDF006282CDQ34993596-0E7A250F-77F1-4979-A7AC-77964A35AF9DQ35032662-9755AF0A-937B-43BE-B43C-14FDA23AC83CQ35048196-282D50A7-A340-465D-9825-63B77082D8E0Q35065243-D013EEBD-F8A6-47FF-85F5-CBCA299F3578Q35134042-4469AE2F-DB73-4862-AD9B-E63332BC95B2Q35158141-6E49B91D-D7D4-4473-9142-C4E1577DBAE6Q35677705-AFB831C5-482A-4BFA-AACF-305995842424Q35678282-105B3C42-5D07-4492-BA5F-803821ABE722Q35954892-4EF9DB0C-2F48-4BF9-98B2-B5AE4691095EQ36143417-DA604DC5-9EFF-495E-9462-5A4B69375AC2Q36235326-EBFBC528-DBAE-4917-A7C6-098D91A16951Q36442777-C92E1479-DE38-43D7-AFC4-F847A6192C09Q36634849-19C71193-CFA1-4861-AFC5-81A4E0800CFDQ36718422-0FE7BAB1-C568-4F84-911D-09B62D5D63CAQ36901888-1A717CFB-07BF-4D46-83EA-18230963D846Q37157739-F042B945-AC6A-49FC-9F32-E3DD3FCC3DA8Q37275499-9DE33015-EB74-446E-AB19-F2D288F503CAQ37362098-8B1C4AC1-01FB-43FB-84B3-088E10385C2BQ37385240-3D2070EC-0244-42F9-A1C3-01D3E52EABC8Q37856044-42903362-BF6F-4AF1-A55E-209D0D8E61C7Q38120512-5192E0A4-CDD9-46BF-B214-95DCD8342A77Q38292744-BC7B6BA8-2DF5-4F36-9D3F-4FD71457138EQ38320920-138B588E-4BFB-4A11-8067-7271BB9A1B96Q38419680-A03CC60E-17CB-47D2-A969-75BF5DF993FDQ38465117-E361F674-12AA-4A42-B34C-05936F4D9374Q38638947-153EC13C-5870-4A6A-8114-A1CA8324A573Q38986185-9951CAC5-7772-46FA-87B4-CF36ACBC6F7CQ39160723-B6A0515B-815C-4968-BFE4-5C60556F92A7Q39210524-3E3414B9-0FD2-428F-BC39-554E27D1C878Q39242775-E0F9A3F8-5A41-470C-ADC3-591EB16F7288Q39252301-B9122B17-5870-4598-858A-71E2341206FBQ40090327-F1F6D57F-4423-47F5-B2EB-FB5774B73F45Q40100374-B55DEB8C-BACD-425F-BEBD-9B31EF9117C3Q40521844-221C1C81-F735-4FED-8546-5E213AED05CCQ40996420-BC2E2E02-DFFB-4D8B-91B7-CAF86DFE7B88
P2860
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@ast
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@en
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@nl
type
label
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@ast
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@en
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@nl
prefLabel
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@ast
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@en
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@nl
P2093
P356
P1433
P1476
Head and neck cancer--Part 1: Epidemiology, presentation, and prevention.
@en
P2093
P356
10.1136/BMJ.C4684
P407
P50
P577
2010-09-20T00:00:00Z